Variant report
Variant | esv3474897 |
---|---|
Chromosome Location | chr11:103914342-103919740 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185166771 | chr11:103914389-103914390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540363657 | chr11:103914417-103914418 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77392305 | chr11:103914451-103914452 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531828985 | chr11:103914513-103914514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76553562 | chr11:103914516-103914517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562047539 | chr11:103914552-103914553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536869353 | chr11:103914578-103914579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114143224 | chr11:103914613-103914614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143819777 | chr11:103914623-103914624 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529133143 | chr11:103914651-103914652 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373925238 | chr11:103914659-103914660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374680506 | chr11:103914667-103914668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs148156192 | chr11:103914671-103914672 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142004928 | chr11:103914748-103914749 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190057550 | chr11:103914752-103914753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539817223 | chr11:103914764-103914765 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562768951 | chr11:103914769-103914770 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570124100 | chr11:103914804-103914805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs116859841 | chr11:103914811-103914812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371801511 | chr11:103914813-103914814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565992448 | chr11:103914875-103914876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181752532 | chr11:103914916-103914917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531530366 | chr11:103914917-103914918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577614450 | chr11:103914977-103914978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543400188 | chr11:103914981-103914982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10750683 | chr11:103915013-103915014 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs573354452 | chr11:103915025-103915026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185337705 | chr11:103915091-103915092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561913826 | chr11:103915120-103915121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145134492 | chr11:103915124-103915125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570549175 | chr11:103915292-103915293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34974666 | chr11:103915326-103915327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541407366 | chr11:103915387-103915388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138948065 | chr11:103915388-103915389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35570444 | chr11:103915389-103915390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376531861 | chr11:103915395-103915396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533245017 | chr11:103915493-103915494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190194393 | chr11:103915514-103915515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570182532 | chr11:103915538-103915539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529368993 | chr11:103915548-103915549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112868243 | chr11:103915559-103915560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565908386 | chr11:103915574-103915575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534816029 | chr11:103915590-103915591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180779570 | chr11:103915635-103915636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571480572 | chr11:103915652-103915653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536648996 | chr11:103915654-103915655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369992350 | chr11:103915685-103915686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs260811 | chr11:103915739-103915740 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs139475926 | chr11:103915755-103915756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574441782 | chr11:103915766-103915767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:103902200-103922800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr11:103908600-103920400 | Weak transcription | Ovary | ovary |
3 | chr11:103912600-103914800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr11:103912600-103914800 | Enhancers | Fetal Intestine Large | intestine |
5 | chr11:103914000-103914400 | Enhancers | A549 | lung |
6 | chr11:103914000-103914600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr11:103914000-103914600 | Enhancers | Gastric | stomach |
8 | chr11:103914000-103914600 | Enhancers | Pancreas | Pancrea |
9 | chr11:103914000-103914800 | Enhancers | Fetal Intestine Small | intestine |
10 | chr11:103914000-103915000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr11:103914200-103914600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr11:103914200-103914600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr11:103914200-103914600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr11:103914200-103914800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr11:103915000-103925600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr11:103917200-103917400 | Enhancers | Fetal Brain Female | brain |
17 | chr11:103917400-103931000 | Weak transcription | Fetal Brain Female | brain |